what is mounjaro tirzepatide FDA approves new version of diabetes drug to be sold for weight loss How Mounjaro® Works for Weight

The exact dosage may change depending on your bodys response to the medical treatment

doi:10.1038/s41419-019-2205-x 44

Consent to participate Written informed consent to participate in this case report was obtained from the patient

Dec 22, 2025, 18:03 ET Average weight loss of ~17% if all patients stayed on treatment * with Wegovy (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on treatment ** ) in the OASIS 4 trial 1 1.5 mg starting dose available in early January for $149 per month with savings offers

One study cited by federal government policymakers found that approximately 53% of patients with overweight or obesity taking semaglutide-based products didnt persist on treatment past two months